Jump to content

NKG7

From Wikipedia, the free encyclopedia
NKG7
Identifiers
AliasesNKG7, GIG1, GMP-17, p15-TIA-1, natural killer cell granule protein 7
External IDsOMIM: 606008; MGI: 1931250; HomoloGene: 4092; GeneCards: NKG7; OMA:NKG7 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_005601
NM_001363693

NM_024253

RefSeq (protein)

NP_005592
NP_001350622

n/a

Location (UCSC)Chr 19: 51.37 – 51.37 MbChr 7: 43.09 – 43.09 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Natural killer cell granule protein 7 (NKG7 protein) is a protein that in humans is encoded by the NKG7 gene. [5] The protein is under study regarding potential in cancer research into T cell activity.[6] A role of the NKG7 protein in regulating cell resistance and fighting tumors in certain types of cancer is being studied because of its ability to recognize and kill cancer cells through CD8+ T cell resilience that is essential for anti-tumor activity. The research suggests that the NKG7 protein allows the CD8+ T cells to continue killing malignant cells in certain circumstances and may prevent growth and metastasis of the malignant cells being attacked by the CD8+ T cells.

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000105374Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000004612Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Entrez Gene: Natural killer cell granule protein 7". Retrieved 2016-02-23.
  6. ^ Gallagher, Colette, Mayo Clinic discovers new role for protein to fight tumors, Mayo Clinic, February 27, 2025

Further reading

[edit]